Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) Net Margin (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Net Margin for 16 consecutive years, with 11.39% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Net Margin fell 1727.0% year-over-year to 11.39%, compared with a TTM value of 7.57% through Sep 2025, down 617.0%, and an annual FY2024 reading of 0.55%, up 993.0% over the prior year.
  • Net Margin was 11.39% for Q3 2025 at Rockwell Medical, down from 9.68% in the prior quarter.
  • Across five years, Net Margin topped out at 5.88% in Q3 2024 and bottomed at 58.32% in Q4 2021.
  • Average Net Margin over 5 years is 20.71%, with a median of 11.39% recorded in 2025.
  • The sharpest move saw Net Margin tumbled -1738bps in 2021, then soared 4610bps in 2022.
  • Year by year, Net Margin stood at 58.32% in 2021, then skyrocketed by 79bps to 12.22% in 2022, then soared by 40bps to 7.3% in 2023, then surged by 57bps to 3.16% in 2024, then tumbled by -261bps to 11.39% in 2025.
  • Business Quant data shows Net Margin for RMTI at 11.39% in Q3 2025, 9.68% in Q2 2025, and 8.31% in Q1 2025.